NOLATO AB SER.B
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more
NOLATO AB SER.B (NBF) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NOLATO AB SER.B (NBF) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NOLATO AB SER.B - Net Assets Trend (None–None)
This chart illustrates how NOLATO AB SER.B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NOLATO AB SER.B (None–None)
The table below shows the annual net assets of NOLATO AB SER.B from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NOLATO AB SER.B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NOLATO AB SER.B Competitors by Market Cap
The table below lists competitors of NOLATO AB SER.B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ADDNODE GROUP AB SK 3
F:AR7
|
$779.20 Million |
|
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082
|
$779.24 Million |
|
ATOSS Software SE
F:AOF
|
$780.09 Million |
|
ACEA S.p.A
OTCGREY:ACEJF
|
$780.10 Million |
|
Electricity Gnrtng NVtg
OTCGREY:EYUUF
|
$778.73 Million |
|
Autobio Diagnostics Co Ltd
SHG:603658
|
$778.70 Million |
|
Qurient Co. Ltd
KQ:115180
|
$778.59 Million |
|
PATTIES FOODS - Frankfurt Stock Exchang
F:PH4
|
$777.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NOLATO AB SER.B's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NOLATO AB SER.B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NOLATO AB SER.B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NOLATO AB SER.B's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NOLATO AB SER.B (NBF) | €- | N/A | N/A | $778.95 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |